Literature DB >> 22238154

Pediatric ulcerative colitis associated with autoimmune diseases: a distinct form of inflammatory bowel disease?

Felipe Ordonez1, Florence Lacaille, Danielle Canioni, Cecile Talbotec, Jean-Christophe Fournet, Nadine Cerf-Bensussan, Olivier Goulet, Jacques Schmitz, Frank M Ruemmele.   

Abstract

BACKGROUND: The pathogenesis of inflammatory bowel disease (IBD) is multifactorial, with some patients presenting additional autoimmune symptoms. Inflammatory colitis associated with autoimmune (AI) liver disease appears to have clinical features different from those of "classical" ulcerative colitis (CUC). The aim of this study was to describe these features, in order to differentiate a subgroup of colitis associated with autoimmunity (CAI) from CUC.
METHODS: Twenty-eight consecutive children with inflammatory colitis associated with primary sclerosing cholangitis (PSC), celiac disease, or AI hepatitis were compared with a matched control group of 27 children with isolated UC. Clinical course, histology, as well as inflammatory profile in the colonic mucosa based on real-time polymerase chain reaction (PCR) were analyzed.
RESULTS: In CAI the main digestive symptoms at disease onset were abdominal pain (12/28) and bloody strings in the stool (12/28), along with a high prevalence of autoimmune diseases in relatives, as compared with bloody diarrhea in the CUC group (26/27). At diagnosis, pancolitis was seen in 18/28 CAI patients compared with 8/27 in UC. In CAI, the pathological findings were different from CUC: 1) major lesions predominantly located in the right colon; 2) pseudo-villous appearance of the mucosa, and strong infiltration with eosinophils; 3) mild glandular lesions; and 4) differing inflammatory infiltrate with reduced FOXP3, interleukin (IL)-2, and thymic stromal lymphopoietin (TSLP) levels. Evolution in CAI was less aggressive, requiring less corticosteroids/immunomodulators.
CONCLUSIONS: Precise clinical, histological, and molecular analyses reveal marked differences between patients with CUC and those with associated AI phenomena, supporting the hypothesis of a distinct AI presentation of IBD.
Copyright © 2012 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22238154     DOI: 10.1002/ibd.22864

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  9 in total

1.  Unique Inflammatory Bowel Disease Phenotype of Pediatric Primary Sclerosing Cholangitis: A Single-Center Study.

Authors:  Henry Shiau; Faith D Ihekweazu; Mansi Amin; Tatiana Fofanova; Tamir Miloh; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-10       Impact factor: 2.839

2.  Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases.

Authors:  Emily C Oxford; Deanna D Nguyen; Jenny Sauk; Joshua R Korzenik; Vijay Yajnik; Sonia Friedman; Ashwin N Ananthakrishnan
Journal:  Am J Gastroenterol       Date:  2013-02-19       Impact factor: 10.864

Review 3.  Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.

Authors:  Ersilia M DeFilippis; Sonal Kumar
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

Review 4.  The IBD and PSC Phenotypes of PSC-IBD.

Authors:  Amanda Ricciuto; Binita M Kamath; Anne M Griffiths
Journal:  Curr Gastroenterol Rep       Date:  2018-03-28

5.  Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review.

Authors:  Luciana Rigoli; Rosario Alberto Caruso
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 6.  Role of thymic stromal lymphopoietin in allergy and beyond.

Authors:  Risa Ebina-Shibuya; Warren J Leonard
Journal:  Nat Rev Immunol       Date:  2022-06-01       Impact factor: 108.555

7.  Increased Cumulative Incidence of Dermatomyositis in Ulcerative Colitis: a Nationwide Cohort Study.

Authors:  Chia-Chun Tseng; Shun-Jen Chang; Wei-Ting Liao; Ya-Ting Chan; Wen-Chan Tsai; Tsan-Teng Ou; Cheng-Chin Wu; Wan-Yu Sung; Ming-Chia Hsieh; Jeng-Hsien Yen
Journal:  Sci Rep       Date:  2016-06-21       Impact factor: 4.379

8.  Twist1 contributes to developing and sustaining corticosteroid resistance in ulcerative colitis.

Authors:  Changqin Liu; Li-Hua Mo; Bai-Sui Feng; Qiao-Ruo Jin; Yan Li; Jianli Lin; Qing Shu; Zhi-Gang Liu; Zhanju Liu; Xiaomin Sun; Ping-Chang Yang
Journal:  Theranostics       Date:  2021-06-26       Impact factor: 11.556

Review 9.  Liver manifestations and complications in inflammatory bowel disease: A review.

Authors:  Rui Gaspar; Catarina Castelo Branco; Guilherme Macedo
Journal:  World J Hepatol       Date:  2021-12-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.